Background Alzheimer's Disease (AD) is a synaptic dysfunction disease; synaptic loss is the
best predictor of cognitive decline. Therefore, a compound that can increase synaptic …

Oral administration of the combination of L-threonate (threonate) and magnesium (Mg 2+) in
the form of L-Threonic acid Magnesium salt (L-TAMS) can enhance learning and memory in …

Background: Cognitive impairment is a major problem in elderly, affecting quality of life. Pre-
clinical studies show that MMFS-01, a synapse density enhancer, is effective at reversing …

Emerging research on the effects of a novel magnesium compound of l-Threonic Acid
Magnesium Salt (l-TAMS) containing Vitamins C and D on cognitive performance suggests …

Background Although repetitive transcranial magnetic stimulation (rTMS) has been
extensively studied in patients with Alzheimer's disease (AD), the clinical evidence remains …

Repetitive transcranial magnetic stimulation (rTMS) uses a magnetic coil to induce an
electric field in brain tissue. As a pilot study, we investigated the effect of rTMS treatment on …

Recent studies have shown that patients with Alzheimer's disease (AD) and its possible
prodromal stage mild cognitive impairment benefit from cognitive interventions. Few studies …

Background High‐frequency, repetitive transcranial magnetic stimulation (rTMS) targeted
over the dorsolateral prefrontal cortex (DLPFC) is widely used in research to promote …

Introduction Amnestic Mild Cognitive Impairment (aMCI) is a prodromal stage to Alzheimer's
disease dementia (AD). Improving prefrontal cortical function in individuals with MCI could …

Background Recent studies and a current randomized controlled trial on a mutlicomponent
cognitive intervention program demonstrated benefits through cognitive intervention in …